Sevelamer Carbonate Tablet, Film Coated
Product Images NDC 50268-720

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Sevelamer Carbonate (NDC 50268-720). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Avpak, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label 800mg (Label 5026872015 Sevelamer 2019 800mg)

Sevelamer Carbonate Tablets are a prescription medication with NDC 50268-720-15 and each box contains 50 film-coated tablets. The active ingredient is 800mg sevelamer carbonate, and the inactive ingredients include diaceyated monoglycerides, hypromellose, microcrystalline cellulose, silicon iodide, and 2 stearate. The usual dosage should be consulted on the package insert. The tablets should be stored between 20° to 25°C. They should be kept away from moisture and out of reach of children. These tablets are manufactured for AVKARE,Inc, Pulaski, T 36478. Manufacturing date is October 2017.*

FDA Label Image

Structure (Sevelamer Carbonate Tablets 1)

FDA Label Image

F-2 (Sevelamer Carbonate Tablets 2)

FDA Label Image

F-3 (Sevelamer Carbonate Tablets 3)

This is data related to the change in phosphorus levels from the baseline in a study conducted with a drug called Sevelamer Hydrochloride. The study was done over multiple weeks, but the exact duration is not specified.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.